Matteucci, F.; Pavletić, P.; Bonifazi, A.; Garland, R.; Yano, H.; Amantini, C.; Zeppa, L.; Sabato, E.; Vistoli, G.; Mammoli, V.;
et al. Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma. Pharmaceuticals 2025, 18, 739.
https://doi.org/10.3390/ph18050739
AMA Style
Matteucci F, Pavletić P, Bonifazi A, Garland R, Yano H, Amantini C, Zeppa L, Sabato E, Vistoli G, Mammoli V,
et al. Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma. Pharmaceuticals. 2025; 18(5):739.
https://doi.org/10.3390/ph18050739
Chicago/Turabian Style
Matteucci, Federica, Pegi Pavletić, Alessandro Bonifazi, Rian Garland, Hideaki Yano, Consuelo Amantini, Laura Zeppa, Emanuela Sabato, Giulio Vistoli, Valerio Mammoli,
and et al. 2025. "Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma" Pharmaceuticals 18, no. 5: 739.
https://doi.org/10.3390/ph18050739
APA Style
Matteucci, F., Pavletić, P., Bonifazi, A., Garland, R., Yano, H., Amantini, C., Zeppa, L., Sabato, E., Vistoli, G., Mammoli, V., Cappellacci, L., Del Bello, F., Giorgioni, G., Petrelli, R., Piergentili, A., Quaglia, W., & Piergentili, A.
(2025). Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma. Pharmaceuticals, 18(5), 739.
https://doi.org/10.3390/ph18050739
